These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29319430)

  • 1. Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.
    Burke SL; Hu T; Fava NM; Li T; Rodriguez MJ; Schuldiner KL; Burgess A; Laird A
    J Women Aging; 2019; 31(2):140-164. PubMed ID: 29319430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
    Horvath A; Quinlan P; Eckerström C; Åberg ND; Wallin A; Svensson J
    J Alzheimers Dis; 2024; 99(2):609-622. PubMed ID: 38701139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of a Relation Between Hippocampal Volume, White Matter Hyperintensities, and Cognition in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Caillaud M; Hudon C; Boller B; Brambati S; Duchesne S; Lorrain D; Gagnon JF; Maltezos S; Mellah S; Phillips N; ; Belleville S
    J Gerontol B Psychol Sci Soc Sci; 2020 Aug; 75(7):1382-1392. PubMed ID: 31758692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
    Soldan A; Pettigrew C; Zhu Y; Wang MC; Moghekar A; Gottesman RF; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M;
    Neurology; 2020 Mar; 94(9):e950-e960. PubMed ID: 31888969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
    J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
    Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
    J Alzheimers Dis; 2021; 80(2):877-883. PubMed ID: 33579856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
    Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM;
    Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White Matter Hyperintensities and Hippocampal Atrophy in Relation to Cognition: The 90+ Study.
    Legdeur N; Visser PJ; Woodworth DC; Muller M; Fletcher E; Maillard P; Scheltens P; DeCarli C; Kawas CH; Corrada MM
    J Am Geriatr Soc; 2019 Sep; 67(9):1827-1834. PubMed ID: 31169919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.
    Brickman AM; Zahodne LB; Guzman VA; Narkhede A; Meier IB; Griffith EY; Provenzano FA; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Mayeux R
    Neurobiol Aging; 2015 Jan; 36(1):27-32. PubMed ID: 25155654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy.
    Fiford CM; Manning EN; Bartlett JW; Cash DM; Malone IB; Ridgway GR; Lehmann M; Leung KK; Sudre CH; Ourselin S; Biessels GJ; Carmichael OT; Fox NC; Cardoso MJ; Barnes J;
    Hippocampus; 2017 Mar; 27(3):249-262. PubMed ID: 27933676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
    Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
    J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.
    Anor CJ; Dadar M; Collins DL; Tartaglia MC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):70-78. PubMed ID: 32389747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study.
    Kim S; Choi SH; Lee YM; Kim MJ; Kim YD; Kim JY; Park JH; Myung W; Na HR; Han HJ; Shim YS; Kim JH; Yoon SJ; Kim SY; Kim DK
    Int Psychogeriatr; 2015 Dec; 27(12):2069-77. PubMed ID: 26212042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.
    Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J
    JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.